drugset / Trial / NCT00162383

Metabolic Capacity of Israeli Populations

NCT00162383

Unknown 1200 enrolled Hadassah Medical Organization
NaSingle-groupOpen-labelOther

Summary

The ability to metabolize drugs varies greatly among individuals. Major fraction of this variability lies in genetic polymorphisms of genes encoding for enzymes responsible for both phase I and phase II reactions. The purpose of this study ws to evaluate the phenotypic activity and the frequency of genetic polymorphisms in different phase II and phase I enzymes among various populations residing in Israel.

Timeline

Start
1995-07
Primary completion
2020-12
Completion
2020-12

Drugs

EvaluationDrugModalityDoseRoute
Background Caffeine Small molecule
Background DEBRISOQUIN Small molecule
Background Dapsone Small molecule
Background Mephenytoin Small molecule

Indications

No indication recorded.